Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fukui

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Urology|September 11, 2001
Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survivalS Kawakami, Y Kageyama, J Yonese, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 19, 1998
Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathyM Yamaguchi, N Nakamura, K Nakano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracyclineM Nakane, S Takahashi, I Sekine, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapyM Fukui, K Nakano, H Shigeta, et al.
Human Immunology|November 24, 1999
Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitusH Obayashi, N Nakamura, M Fukui, et al.
Biochemical and Biophysical Research Communications|September 4, 1996
Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivoH Obayashi, K Nakano, H Shigeta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignanciesR Ohno, Y Yamaguchi, T Toge, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Urology|September 11, 2001
Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survivalS Kawakami, Y Kageyama, J Yonese, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 19, 1998
Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathyM Yamaguchi, N Nakamura, K Nakano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracyclineM Nakane, S Takahashi, I Sekine, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapyM Fukui, K Nakano, H Shigeta, et al.
Human Immunology|November 24, 1999
Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitusH Obayashi, N Nakamura, M Fukui, et al.
Biochemical and Biophysical Research Communications|September 4, 1996
Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivoH Obayashi, K Nakano, H Shigeta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignanciesR Ohno, Y Yamaguchi, T Toge, et al.
Pageof 20